Matinas BioPharma

+$0.0163 (+1.87%) Today
+$0.0299 (+3.36%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MTNB and other stocks, options, and ETFs commission-free!

About MTNB

Matinas BioPharma Holdings, Inc., also called Matinas BioPharma, is a clinical-stage biopharmaceutical company, which focuses on enabling the delivery of life-changing medicines using its LNC platform technology. The company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins, and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable.

CEO
Jerome D. Jabbour
Employees
20
Headquarters
Bedminster, New Jersey
Founded
2013

MTNB Key Statistics

Market Cap
181.83M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.22M
High Today
$0.9399
Low Today
$0.8929
Open Price
$0.90
Volume
2.20M
52 Week High
$2.22
52 Week Low
$0.661

MTNB Earnings

-$0.04
-$0.03
-$0.01
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure